Latin America Continuous Glucose Monitoring Device Marketembed
Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement.
Latin America Continuous Glucose Monitoring Device Market Trends And Outlook 2018-2026 Continuous glucose monitoring devices have the potential to improve clinical outcomes for avoiding hypo/hyperglycemic events, an outcome of uncontrolled diabetes, which can arise due to skipped insulin dose. The currently available CGM devices display the glucose level and the magnitude and direction of changing glucose levels, thus becoming a vital tool to predict the forthcoming events of hypo- and hyperglycemia. Moreover, the device is more convenient for type 1 diabetic patients, as it requires continuous monitoring of glucose for administration of insulin on regular basis. Thus, use and benefits of CGM device in controlling both type 1 diabetes and hypoglycemia & hyperglycemia is expected to drive the market growth. Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2993 The Latin America continuous glucose monitoring device market was valued at US$ 126.2 million in 2018 and is expected to witness a CAGR of 15.9% during the forecast period (2018– 2026). Increasing initiative by key players for distribution of continuous monitoring device in Latin America is expected to boost growth of Latin America continuous glucose monitoring device market Major players are adopting inorganic growth strategies such as collaboration, in order to distribute their products in Latin America and increase their market share in the region. For instance, in February 2019, Senseonics Holdings, Inc. announced expansion of distribution agreement with Roche Diabetes Care by providing them with exclusive distribution rights, for distribution of implantable continuous glucose monitoring (CGM) system, in 17 countries including Brazil, Russia, India, and China as well as selected markets in the Asia Pacific and Latin American regions. Moreover, increasing product launches by key players also contribute to growth of Latin America continuous glucose monitoring device market. Insulin pumps segment is expected to witness significant growth over the forecast period, owing to increasing product launches of insulin pumps for continuous glucose monitoring. For instance, in March 2019, Medtronic Plc. launched MiniMed 670G system, a self-adjusting insulin pump system for patients who have type 1 diabetes, in the U.K. Medtronic Plc. also supplies diabetic care products in Latin American countries such as Brazil, Chile, Colombia, and others. Report includes chapters which deeply display the following deliverable about industry : • Latin America Continuous Glucose Monitoring Device Market Research Objective and Assumption • Latin America Continuous Glucose Monitoring Device Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Latin America Continuous Glucose Monitoring Device Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Latin America Continuous Glucose Monitoring Device Market, By Regions • Latin America Continuous Glucose Monitoring Device Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Latin America Continuous Glucose Monitoring Device Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Latin America Continuous Glucose Monitoring Device Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Latin America Continuous Glucose Monitoring Device Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Market Dynamics Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device in this region. For instance, according to Global Burden of Disease Study 2016, the incidence rate of diabetes in Latin America increased from 2.74% in 2010 to 3.06% in 2016. Among all countries in Latin America, diabetes affects large number of adult population based in Mexico and Brazil. Latin America Continuous Glucose Monitoring Device Market- Competitive Landscape Key players operating in Latin America continuous glucose monitoring device market include Medtronic Plc, Abbott, F. Hoffmann-La Roche AG, Johnson & Johnson, Senseonics, Inc, Dexcom, Inc., Insulet Corporation, and Tandem Diabetes Care, Inc. For More Details On this Report: https://www.coherentmarketinsights.com/market-insight/latinamerica-continuous-glucose-monitoring-cgm-device-market-2993 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702